← Back to Search

Community Support Intervention for Substance Use Disorder

Phase 2
Waitlist Available
Led By Michael Kidorf, Ph.D.
Research Sponsored by Johns Hopkins University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up monthly for 3 months
Awards & highlights
No Placebo-Only Group

Summary

Efforts to improve methadone maintenance outcomes are often thwarted by strong social networks that reinforce substance use and other risk behaviors. The proposed study the feasibility and preliminary efficacy of a practical community support intervention that employs an alteration model of social network change. The intervention works with patients and at least one drug-free family or friend to support participation in community activities designed to mobilize recovery support and expand personal drug-free social networks.

Eligible Conditions
  • Substance Use Disorder

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~monthly for 3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and monthly for 3 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Behavioral and attitudinal support for abstinence as assessed by the IPA
Perceived social support for designated CSP as assessed by the Quality of Relationships Inventory (QRI) "support scale"
Secondary study objectives
Substance use and problem severity as assessed by urinalysis testing and Addiction Treatment Index (ASI) composite scores

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Community Support InterventionExperimental Treatment1 Intervention
Participants randomized to this condition will be scheduled to attend a 12-week (1x/wk for one hour) manual-guided Community Support Intervention Group, which requires methadone maintenance treatment (MMT) participants to attend the group with a drug-free family member or friend (community support person; CSP).
Group II: Standard CareActive Control1 Intervention
Participants randomized to this condition will be scheduled to attend a 12-week (1x/wk for one hour) manual-guided Substance Use Disorder Educational Group as an attention-control for the intervention described in the experimental condition.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Community Support Intervention Group
2018
Completed Phase 2
~50

Find a Location

Who is running the clinical trial?

Johns Hopkins UniversityLead Sponsor
2,324 Previous Clinical Trials
14,874,451 Total Patients Enrolled
National Institute on Drug Abuse (NIDA)NIH
2,585 Previous Clinical Trials
3,328,181 Total Patients Enrolled
Michael Kidorf, Ph.D.Principal InvestigatorJohns Hopkins University
2 Previous Clinical Trials
381 Total Patients Enrolled
~6 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top